AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Levocetirizine Dihydrochloride in Nigeria
8 products registered with NAFDAC — 8 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Histolat Tablets Tablet | A11-100022 | Afrab-Chem Limited | active | 27 Apr 2031 |
| Levocetirizine Dihydrochloride Syrup 2.5 mg/5 mL Syrup | C4-0067 | Unosource Pharma Nigeria Limited | active | 30 Jul 2029 |
| Xyzal Tablets 5 mg** Tablet | A4-6915 | GlaxoSmithKline Consumer Nigeria PLC (GSK) | active | 26 Jul 2028 |
| Histolat Syrup Syrup | A11-100023 | Afrab-Chem Limited | active | 28 Mar 2026 |
| Glencet Tablets (check product description, check pack size) Tablet | B4-3090 | Glenmark Pharmaceuticals Nigeria Limited | active | 28 Feb 2026 |
| Utilev Syrup Syrup | B4-5990 | Healthline Limited | active | 28 Feb 2026 |
| Fitin-5 Tablet Tablet | C4-1347 | TAH Pharmaceuticals Limited | active | 20 Dec 2025 |
| Rizcet Tablets Tablet | B4-3806 | Astranad Pharmaceuticals and Chemical Company Limited | active | 9 Nov 2025 |
Levocetirizine Dihydrochloride — NAFDAC Registration Details
NAFDAC (Nigeria) has 8 registered products containing Levocetirizine Dihydrochloride, of which 8 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Levocetirizine Dihydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.